Cost-effectiveness of encorafenib with binimetinib in unresectable or metastatic BRAF-mutant melanoma [0.03%]
恩考芬尼联合比美替尼治疗不可切除或转移性BRAF突变型黑色素瘤的成本效益分析
Jean-Baptiste Trouiller,Georgios F Nikolaidis,Bérengère Macabeo et al.
Jean-Baptiste Trouiller et al.
Objective: The objective of this study was to determine the cost-effectiveness of encorafenib with binimetinib (EncoBini) as compared to other targeted double combination therapies, namely dabrafenib with trametinib (Dabr...
The effect of telephone health coaching and remote exercise monitoring for peripheral artery disease (TeGeCoach) on health care cost and utilization: results of a randomized controlled trial [0.03%]
针对外周动脉疾病的电话健康辅导和远程运动监测对医疗费用和利用率的影响：随机对照试验结果
Dirk Heider,Farhad Rezvani,Herbert Matschinger et al.
Dirk Heider et al.
Background: Peripheral artery disease (PAD) is the third most prevalent atherosclerotic cardiovascular disease. In 2016, costs per patient associated with PAD exceeded even the health-economic burden of coronary heart dis...
Competition and collaboration in health care: reconciling the irreconcilable? Lessons from The Netherlands [0.03%]
医疗卫生领域的竞争与合作：不可调和还是相辅相成？荷兰的启示
Marco Varkevisser,Frédérique Franken,Stéphanie van der Geest et al.
Marco Varkevisser et al.
The effect of duration and time preference on the gap between adult and child health state valuations in time trade-off [0.03%]
时长和时间偏好对成人与儿童健康状况估值差距的影响——时间贸易off研究
Zhongyu Lang,Arthur E Attema,Stefan A Lipman
Zhongyu Lang
Composite time trade-off (cTTO) utilities have been found to be higher when adults value health states for children than for themselves. It is not clear if these differences reflect adults assigning truly higher utilities to the same health...
Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study [0.03%]
过敏性呼吸道疾病患者的生存质量及医疗费用：横断面研究
Vivienne Hillerich,Frederik Valbert,Silke Neusser et al.
Vivienne Hillerich et al.
Background: Allergic rhinitis (AR) and allergic asthma (AA) are chronic respiratory diseases that represent a global health problem. One aim of this study was to analyze the Health-related Quality of Life (HRQoL) of the p...
Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic [0.03%]
勇闯波浪：欧洲七国新冠疫情期间的能力福祉模式探究
Sebastian Himmler,Job van Exel,Werner Brouwer et al.
Sebastian Himmler et al.
The COVID-19 pandemic considerably impacted the lives of European citizens. This study aims to provide a nuanced picture of well-being patterns during the pandemic across Europe with a special focus on relevant socio-economic sub-groups. Th...
Psychometric properties and general population reference values for PROMIS Global Health in Hungary [0.03%]
匈牙利PROMIS全球健康量表的计量学特性及其在普通人群中的参考值
Alex Bató,Valentin Brodszky,Ariel Zoltán Mitev et al.
Alex Bató et al.
Objectives: Patient-Reported Outcomes Measurement Information System-Global Health (PROMIS-GH) is a widely used generic measure of health status. This study aimed to (1) assess the psychometric properties of the Hungarian...
Mapping from SIBDQ to EQ-5D-5L for patients with inflammatory bowel disease [0.03%]
从炎症性肠病患者的角度看SIBDQ到EQ-5D-5L的映射关系
Isa Maria Steiner,Bernd Bokemeyer,Tom Stargardt
Isa Maria Steiner
Objective: Clinical studies commonly use disease-specific measures to assess patients' health-related quality of life. However, economic evaluation often requires preference-based utility index scores to calculate cost pe...
Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment [0.03%]
德国引入AMNOG法规对新药上市延迟的影响：一则评论
Afschin Gandjour
Afschin Gandjour
"COVID-19 and income inequality in OECD countries:" A methodological comment [0.03%]
“新冠疫情与经合组织国家的收入不平等：一种方法论的解读”
Oded Stark
Oded Stark
Wildman (2021), who identifies "a clear association between income inequality [measured by the Gini coefficient] and COVID-19 cases and deaths," concludes that "a goal of government should be to reduce [income] inequalities and [thereby] im...